ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 12, Issue 10, Pages 573-583
Publisher
Springer Nature
Online
2015-06-30
DOI
10.1038/nrclinonc.2015.117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
- (2015) Richard S Finn et al. LANCET ONCOLOGY
- Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
- (2015) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESR1 Amplification is Rare in Breast Cancer and is Associated with High Grade and High Proliferation: A Multiplex Ligation-Dependent Probe Amplification Study
- (2015) Cathy B. Moelans et al. Analytical Cellular Pathology
- Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
- (2014) Suzanne A. W. Fuqua et al. BREAST CANCER RESEARCH AND TREATMENT
- Bufalin Is a Potent Small-Molecule Inhibitor of the Steroid Receptor Coactivators SRC-3 and SRC-1
- (2014) Y. Wang et al. CANCER RESEARCH
- Therapeutic Strategies Utilized in the Setting of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
- (2014) H. A. Yu et al. CLINICAL CANCER RESEARCH
- Emergence of Constitutively Active Estrogen Receptor- Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
- (2014) R. Jeselsohn et al. CLINICAL CANCER RESEARCH
- Considerations for Digital PCR as an Accurate Molecular Diagnostic Tool
- (2014) J. F. Huggett et al. CLINICAL CHEMISTRY
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors
- (2014) Osama E Rahma et al. Journal of Translational Medicine
- Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast
- (2014) Salvatore Piscuoglio et al. Molecular Oncology
- Clonal evolution in breast cancer revealed by single nucleus genome sequencing
- (2014) Yong Wang et al. NATURE
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Identification of Verrucarin A as a Potent and Selective Steroid Receptor Coactivator-3 Small Molecule Inhibitor
- (2014) Fei Yan et al. PLoS One
- Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
- (2014) M. Yu et al. SCIENCE
- The Optimal Duration of Adjuvant Endocrine Therapy for Early Stage Breast Cancer—With What Drugs and for How Long?
- (2014) Stephen R. D. Johnston et al. Current Oncology Reports
- Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers
- (2014) Jamunarani Veeraraghavan et al. Nature Communications
- D538G Mutation in Estrogen Receptor- : A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
- (2013) K. Merenbakh-Lamin et al. CANCER RESEARCH
- Extending the Clinical Benefit of Endocrine Therapy for Women With Hormone Receptor–Positive Metastatic Breast Cancer: Differentiating Mechanisms of Action
- (2013) Stefan Glück Clinical Breast Cancer
- The renaissance of endocrine therapy in breast cancer
- (2013) Nicole Williams et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells
- (2013) Albana Gattelli et al. EMBO Molecular Medicine
- Use of SERMs for treatment in postmenopausal women
- (2013) JoAnn V. Pinkerton et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Enhanced PI3K p110 Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a p110 -Selective PI3K Inhibitor
- (2013) S. W. Brady et al. MOLECULAR CANCER THERAPEUTICS
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Activating ESR1 mutations in hormone-resistant metastatic breast cancer
- (2013) Dan R Robinson et al. NATURE GENETICS
- Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study
- (2013) Stephen X. Skapek et al. PEDIATRIC BLOOD & CANCER
- Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
- (2013) Shunqiang Li et al. Cell Reports
- Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer
- (2013) L-Y Huw et al. Oncogenesis
- Potential of Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer
- (2012) Jing Peng et al. Anti-Cancer Agents in Medicinal Chemistry
- Estrogen receptors and human disease: an update
- (2012) Katherine A. Burns et al. ARCHIVES OF TOXICOLOGY
- Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases
- (2012) Laurien D. C. Hoefnagel et al. CANCER
- Elusive Extranuclear Estrogen Receptors in Breast Cancer
- (2012) E. R. Levin CLINICAL CANCER RESEARCH
- Breast cancer intratumor genetic heterogeneity: causes and implications
- (2012) Charlotte KY Ng et al. Expert Review of Anticancer Therapy
- Improving T cell responses to modified peptides in tumor vaccines
- (2012) Jonathan D. Buhrman et al. IMMUNOLOGIC RESEARCH
- ESR1 amplification in breast cancer: controversy resolved?
- (2012) Donna G Albertson JOURNAL OF PATHOLOGY
- Genetic heterogeneity and cancer drug resistance
- (2012) Nicholas C Turner et al. LANCET ONCOLOGY
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Detection of ultra-rare mutations by next-generation sequencing
- (2012) M. W. Schmitt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HER2 Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in EGFR -Mutant Lung Cancers That Lack the Second-Site EGFR T790M Mutation
- (2012) Ken Takezawa et al. Cancer Discovery
- Acquired resistance to drugs targeting receptor tyrosine kinases
- (2011) Steven A. Rosenzweig BIOCHEMICAL PHARMACOLOGY
- Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment
- (2011) S C Drury et al. ENDOCRINE-RELATED CANCER
- Gene amplification of ESR1 in breast cancers-fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study
- (2011) Akishi Ooi et al. JOURNAL OF PATHOLOGY
- Progress in endocrine approaches to the treatment and prevention of breast cancer
- (2011) Ifeyinwa Obiorah et al. MATURITAS
- Direct mutation analysis by high-throughput sequencing: From germline to low-abundant, somatic variants
- (2011) Michael Gundry et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection and quantification of rare mutations with massively parallel sequencing
- (2011) I. Kinde et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- WNT11 Expression Is Induced by Estrogen-Related Receptor and -Catenin and Acts in an Autocrine Manner to Increase Cancer Cell Migration
- (2010) M. A. Dwyer et al. CANCER RESEARCH
- New Strategies in Estrogen Receptor-Positive Breast Cancer
- (2010) S. R. D. Johnston CLINICAL CANCER RESEARCH
- Growth factor stimulation induces a distinct ER cistrome underlying breast cancer endocrine resistance
- (2010) M. Lupien et al. GENES & DEVELOPMENT
- Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
- (2010) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
- Advances in understanding cancer genomes through second-generation sequencing
- (2010) Matthew Meyerson et al. NATURE REVIEWS GENETICS
- Phosphorylation of the mutant K303R estrogen receptor α at serine 305 affects aromatase inhibitor sensitivity
- (2010) I Barone et al. ONCOGENE
- Cancer research: from folate antagonism to molecular targets
- (2009) Joseph R. Bertino BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305
- (2009) Cinzia Giordano et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogen receptor α geneESR1amplification may predict endocrine therapy responsiveness in breast cancer patients
- (2009) Saori Tomita et al. CANCER SCIENCE
- The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer
- (2009) Melanie Spears et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Absence of ESR1 amplification in a series of breast cancers
- (2008) José Adélaïde et al. INTERNATIONAL JOURNAL OF CANCER
- Next-generation DNA sequencing
- (2008) Jay Shendure et al. NATURE BIOTECHNOLOGY
- NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses
- (2008) Kendall W Nettles et al. Nature Chemical Biology
- ESR1 gene amplification in breast cancer: a common phenomenon?
- (2008) Anne Vincent-Salomon et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More